EBIT at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's EBIT?
- Arbutus Biopharma Corporation (ABUS) reported EBIT of $168.91M in Q1 2026.
- How has Arbutus Biopharma Corporation's EBIT changed year-over-year?
- Arbutus Biopharma Corporation's EBIT increased by 757.3% year-over-year, from -$25.7M to $168.91M.
- What is the long-term trend for Arbutus Biopharma Corporation's EBIT?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's EBIT has grown at a -15.1% compound annual growth rate (CAGR), from -$73.52M to -$38.16M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.